Quality of ulcer healing in gastrointestinal tract: Its pathophysiology and clinical relevance

被引:73
作者
Arakawa, Tetsuo [1 ]
Watanabe, Toshio [1 ]
Tanigawa, Tetsuya [1 ]
Tominaga, Kazunari [1 ]
Fujiwara, Yasuhiro [1 ]
Morimoto, Ken'ichi [1 ]
机构
[1] Osaka City Univ, Dept Gastroenterol, Grad Sch Med, Abeno Ku, Osaka 5458585, Japan
关键词
Quality of ulcer healing; Peptic ulcer disease; Recurrence; Prostaglandin; Cytokines; Growth factors; RAT GASTRIC-ULCER; HELICOBACTER-PYLORI; INFLAMMATORY RESPONSE; CROHNS-DISEASE; RECURRENCE; REBAMIPIDE; MECHANISMS; PROTECTION; RELAPSE; PROSTAGLANDINS;
D O I
10.3748/wjg.v18.i35.4811
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
In this paper, we review the concept of quality of ulcer healing (QOUH) in the gastrointestinal tract and its role in the ulcer recurrence. In the past, peptic ulcer disease (PUD) has been a chronic disease with a cycle of repeated healing/remission and recurrence. The main etiological factor of PUD is Helicobacter pylori (H. pylori), which is also the cause of ulcer recurrence. However, H. pylori-negative ulcers are present in 12%-20% of patients; they also recur and are on occasion intractable. QOUH focuses on the fact that mucosal and submucosal structures within ulcer scars are incompletely regenerated. Within the scars of healed ulcers, regenerated tissue is immature and with distorted architecture, suggesting poor QOUH. The abnormalities in mucosal regeneration can be the basis for ulcer recurrence. Our studies have shown that persistence of macrophages in the regenerated area plays a key role in ulcer recurrence. Our studies in a rat model of ulcer recurrence have indicated that proinflammatory cytokines trigger activation of macrophages, which in turn produce increased amounts of cytokines and chemokines, which attract neutrophils to the regenerated area. Neutrophils release proteolytic enzymes that destroy the tissue, resulting in ulcer recurrence. Another important factor in poor QOUH can be deficiency of endogenous prostaglandins and a deficiency and/or an imbalance of endogenous growth factors. Topically active mucosal protective and antiulcer drugs promote high QOUH and reduce inflammatory cell infiltration in the ulcer scar. In addition to PUD, the concept of QOUH is likely applicable to inflammatory bowel diseases including Crohn's disease and ulcerative colitis. (c) 2012 Baishideng. All rights reserved.
引用
收藏
页码:4811 / 4822
页数:12
相关论文
共 48 条
[1]
Altered vascular response to acetylcholine in conditions of endothelial damage in the isolated perfused rat stomach [J].
Abe, Y ;
Itoh, K ;
Arakawa, Y .
JOURNAL OF GASTROENTEROLOGY, 2000, 35 (02) :93-98
[2]
Prostaglandins in the stomach: An update [J].
Arakawa, T ;
Higuchi, K ;
Fukuda, T ;
Fujiwara, Y ;
Kobayashi, K ;
Kuroki, T .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1998, 27 :S1-S11
[3]
REBAMIPIDE, NOVEL PROSTAGLANDIN-INDUCER, ACCELERATES HEALING AND REDUCES RELAPSE OF ACETIC ACID-INDUCED RAT GASTRIC-ULCER - COMPARISON WITH CIMETIDINE [J].
ARAKAWA, T ;
WATANABE, T ;
FUKUDA, T ;
YAMASAKI, K ;
KOBAYASHI, K .
DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (11) :2469-2472
[4]
GASTRIC-MUCOSAL RESISTANCE AND PROSTANOID LEVELS AFTER CIMETIDINE TREATMENT IN RATS [J].
ARAKAWA, T ;
SATOH, H ;
FUKUDA, T ;
SAKUMA, H ;
NAKAMURA, H ;
KOBAYASHI, K .
DIGESTION, 1988, 41 (01) :1-8
[5]
QUALITY OF ULCER HEALING - A NEW CONCEPT TO RANK HEALED PEPTIC-ULCERS [J].
ARAKAWA, T ;
KOBAYASHI, K .
GASTROENTEROLOGIA JAPONICA, 1993, 28 :158-162
[6]
Arakawa T, 1998, DIGEST DIS SCI, V43, p61S
[7]
15th anniversary of rebamipide: Looking ahead to the new mechanisms and new applications [J].
Arakawa, T ;
Higuchi, K ;
Fujiwara, Y ;
Watanabe, T ;
Tominaga, K ;
Sasaki, E ;
Oshitani, N ;
Yoshikawa, T ;
Tarnawski, AS .
DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (Suppl 1) :S3-S11
[8]
Indomethacin treatment during initial period of acetic acid-induced rat gastric ulcer healing promotes persistent polymorphonuclear cell-infiltration and increases future ulcer recurrence - Possible mediation of prostaglandins [J].
Arakawa, T ;
Watanabe, T ;
Fukuda, T ;
Higuchi, K ;
Takaishi, O ;
Yamasaki, K ;
Kobayashi, K ;
Tarnawski, A .
DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (10) :2055-2061
[9]
ARAKAWA T, 1993, EUR J GASTROEN HEPAT, V5, pS87
[10]
Arakawa T, 1998, DIGEST DIS SCI, V43, p5S